1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine has been researched along with 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine in 1 studies
| Studies (1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine) | Trials (1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine) | Recent Studies (post-2010) (1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine) | Studies (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) | Trials (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) |
|---|---|---|---|---|---|
| 11 | 0 | 1 | 9 | 0 | 1 |
| Protein | Taxonomy | 1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine (IC50) | 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine (IC50) |
|---|---|---|---|
| N-acetyltransferase Eis | Mycobacterium tuberculosis H37Rv | 0.56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garneau-Tsodikova, S; Garzan, A; Green, KD; Holbrook, SYL; Hou, C; Krieger, K; Pang, AH; Parish, T; Posey, JE; Punetha, A; Thamban Chandrika, N; Tsodikov, OV; Willby, MJ | 1 |
1 other study(ies) available for 1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine and 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from
Topics: | 2021 |